Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Chinese Journal of Experimental Traditional Medical Formulae ; (24): 73-80, 2022.
Article in Chinese | WPRIM | ID: wpr-940177

ABSTRACT

ObjectiveTo screen out the extended spectrum beta-lactamase (ESBL)-producing Escherichia coli with the strongest biofilm-forming ability through experiments, and discuss the effect of modified Dayuansan (MDYS) combined with imipenem-cilastatin and cilastatin sodium on the biofilm of E. coli. MethodThe paper diffusion and crystal violet staining methods were used to identify 19 clinically isolated strains of drug-resistant E. coli-induced enzymes and the biofilm-forming ability. The induced enzymes and the E. coli with the strongest biofilm-forming ability were screened out. The minimum inhibitory concentration (MIC) value of MDYS and imipenem-cilastatin and cilastatin sodium was determined by 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxamide (XTT) assay. The 1/2, 1/4, and 1/8 MIC of the water extract of MDYS, imipenem-cilastatin and cilastatin sodium alone, and MDYS combined with imipenem-cilastatin and cilastatin sodium was determined by methyl thiazolyl tetrazolium (MTT) assay to obtain the optimum concentration of drugs. BioFlux dynamically observed the effect of the optimum combined drug concentration on the number of bacteria in the biofilm and the biofilm formation of E. coli, and observed the distribution of live/dead bacteria with a laser confocal scanning microscope. Finally, the morphological changes in bacteria after drug treatment were observed statically by scanning electron microscopy. ResultE5E7 strain was ESBL enzyme and the E. coli with the strongest biofilm-forming ability. The results of MTT assay showed that the MIC values of the water extracts of imipenem-cilastatin and cilastatin sodium and MDYS were 1 mg·L-1 and 250 g·L-1, respectively. The results of XTT assay showed that compared with the blank group, the 1/2, 1/4, and 1/8 MIC MDYS groups and the combined drug groups significantly decreased the number of bacteria in the biofilm (P<0.01). The inhibitory effect diminished as the concentration of imipenem-cilastatin and cilastatin sodium decreased. Compared with the imipenem-cilastatin and cilastatin sodium group with the same concentration, the combined drug group improved the inhibitory effect on the number of bacteria in the biofilm (P<0.01). Compared with the MDYS group with the same concentration, 1/2 MIC imipenem-cilastatin and cilastatin sodium combined with 1/2, 1/4, and 1/8 MIC MDYS, 1/4 MIC imipenem-cilastatin and cilastatin sodium combined with 1/2 and 1/4 MIC MDYS, and 1/8 MIC imipenem-cilastatin and cilastatin sodium combined with 1/2 and 1/4 MIC MDYS decreased the number of bacteria (P<0.05, P<0.01). The results of BioFlux showed that compared with the blank group, the 1/2 and 1/8 MIC imipenem-cilastatin and cilastatin sodium groups had an insignificant effect on the area of biofilm, whereas the 1/2 and 1/4 MIC MDYS groups significantly decreased the area of biofilm. The results under the scanning electron microscopy showed that as compared with the blank group and the imipenem-cilastatin and cilastatin sodium group, the division cycle was significantly longer under the action of MDYS combined with imipenem-cilastatin and cilastatin sodium. The length of the division cycle in the combined drug group was higher than that in drug alone group. ConclusionIn vitro studies reveal that MDYS combined with commonly-used antibiotics can inhibit the biofilm status of multi-drug resistant E. coli, and MDYS has the effect of enhancing sensitization and inhibiting bacteria with synergistic antibiotics.

2.
Chinese Journal of Experimental Traditional Medical Formulae ; (24): 73-80, 2022.
Article in Chinese | WPRIM | ID: wpr-940145

ABSTRACT

ObjectiveTo screen out the extended spectrum beta-lactamase (ESBL)-producing Escherichia coli with the strongest biofilm-forming ability through experiments, and discuss the effect of modified Dayuansan (MDYS) combined with imipenem-cilastatin and cilastatin sodium on the biofilm of E. coli. MethodThe paper diffusion and crystal violet staining methods were used to identify 19 clinically isolated strains of drug-resistant E. coli-induced enzymes and the biofilm-forming ability. The induced enzymes and the E. coli with the strongest biofilm-forming ability were screened out. The minimum inhibitory concentration (MIC) value of MDYS and imipenem-cilastatin and cilastatin sodium was determined by 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxamide (XTT) assay. The 1/2, 1/4, and 1/8 MIC of the water extract of MDYS, imipenem-cilastatin and cilastatin sodium alone, and MDYS combined with imipenem-cilastatin and cilastatin sodium was determined by methyl thiazolyl tetrazolium (MTT) assay to obtain the optimum concentration of drugs. BioFlux dynamically observed the effect of the optimum combined drug concentration on the number of bacteria in the biofilm and the biofilm formation of E. coli, and observed the distribution of live/dead bacteria with a laser confocal scanning microscope. Finally, the morphological changes in bacteria after drug treatment were observed statically by scanning electron microscopy. ResultE5E7 strain was ESBL enzyme and the E. coli with the strongest biofilm-forming ability. The results of MTT assay showed that the MIC values of the water extracts of imipenem-cilastatin and cilastatin sodium and MDYS were 1 mg·L-1 and 250 g·L-1, respectively. The results of XTT assay showed that compared with the blank group, the 1/2, 1/4, and 1/8 MIC MDYS groups and the combined drug groups significantly decreased the number of bacteria in the biofilm (P<0.01). The inhibitory effect diminished as the concentration of imipenem-cilastatin and cilastatin sodium decreased. Compared with the imipenem-cilastatin and cilastatin sodium group with the same concentration, the combined drug group improved the inhibitory effect on the number of bacteria in the biofilm (P<0.01). Compared with the MDYS group with the same concentration, 1/2 MIC imipenem-cilastatin and cilastatin sodium combined with 1/2, 1/4, and 1/8 MIC MDYS, 1/4 MIC imipenem-cilastatin and cilastatin sodium combined with 1/2 and 1/4 MIC MDYS, and 1/8 MIC imipenem-cilastatin and cilastatin sodium combined with 1/2 and 1/4 MIC MDYS decreased the number of bacteria (P<0.05, P<0.01). The results of BioFlux showed that compared with the blank group, the 1/2 and 1/8 MIC imipenem-cilastatin and cilastatin sodium groups had an insignificant effect on the area of biofilm, whereas the 1/2 and 1/4 MIC MDYS groups significantly decreased the area of biofilm. The results under the scanning electron microscopy showed that as compared with the blank group and the imipenem-cilastatin and cilastatin sodium group, the division cycle was significantly longer under the action of MDYS combined with imipenem-cilastatin and cilastatin sodium. The length of the division cycle in the combined drug group was higher than that in drug alone group. ConclusionIn vitro studies reveal that MDYS combined with commonly-used antibiotics can inhibit the biofilm status of multi-drug resistant E. coli, and MDYS has the effect of enhancing sensitization and inhibiting bacteria with synergistic antibiotics.

3.
Chinese Journal of Biotechnology ; (12): 15-29, 2021.
Article in Chinese | WPRIM | ID: wpr-878539

ABSTRACT

Lignocellulose can be hydrolyzed by cellulase into fermentable sugars to produce hydrogen, ethanol, butanol and other biofuels with added value. Pretreatment is a critical step in biomass conversion, but also generates inhibitors with negative impacts on subsequent enzymatic hydrolysis and fermentation. Hence, pretreatment and detoxification methods are the basis of efficient biomass conversion. Commonly used pretreatment methods of lignocellulose are chemical and physic-chemical processes. Here, we introduce different inhibitors and their inhibitory mechanisms, and summarize various detoxification methods. Moreover, we propose research directions for detoxification of inhibitors generated during lignocellulose pretreatment.


Subject(s)
Biofuels , Biomass , Fermentation , Hydrolysis , Lignin/metabolism
4.
Mem. Inst. Oswaldo Cruz ; 115: e190348, 2020. tab, graf
Article in English | LILACS | ID: biblio-1056773

ABSTRACT

BACKGROUND It was previously demonstrated that CMC-20, a nitazoxanide and N-methyl-1H-benzimidazole hybrid molecule, had higher in vitro activity against Giardia intestinalis WB strain than metronidazole and albendazole and similar to nitazoxanide. OBJETIVES To evaluate the in vitro activity of CMC-20 against G. intestinalis strains with different susceptibility/resistance to albendazole and nitazoxanide and evaluate its effect on the distribution of parasite cytoskeletal proteins and its in vivo giardicidal activity. METHODS CMC-20 activity was tested against two isolates from patients with chronic and acute giardiasis, an experimentally induced albendazole resistant strain and a nitazoxanide resistant clinical isolate. CMC-20 effect on the distribution of parasite cytoskeletal proteins was analysed by indirect immunofluorescence and its activity was evaluated in a murine model of giardiasis. FINDINGS CMC-20 showed broad activity against susceptible and resistant strains to albendazole and nitaxozanide. It affected the parasite microtubule reservoir and triggered the parasite encystation. In this process, alpha-7.2 giardin co-localised with CWP-1 protein. CMC-20 reduced the infection time and cyst load in feces of G. muris infected mice similar to albendazole. MAIN CONCLUSIONS The in vitro and in vivo giardicidal activity of CMC-20 suggests its potential use in the treatment of giardiasis.


Subject(s)
Humans , Animals , Mice , Thiazoles/pharmacology , Albendazole/pharmacology , Giardia lamblia/drug effects , Cytoskeletal Proteins/drug effects , Antiprotozoal Agents/pharmacology , Thiazoles/chemistry , Time Factors , Albendazole/chemistry , Fluorescent Antibody Technique, Indirect , Parasitic Sensitivity Tests , Antiprotozoal Agents/chemistry
5.
Mem. Inst. Oswaldo Cruz ; 115: e190348, 2020. tab, graf
Article in English | LILACS | ID: biblio-1091246

ABSTRACT

BACKGROUND It was previously demonstrated that CMC-20, a nitazoxanide and N-methyl-1H-benzimidazole hybrid molecule, had higher in vitro activity against Giardia intestinalis WB strain than metronidazole and albendazole and similar to nitazoxanide. OBJETIVES To evaluate the in vitro activity of CMC-20 against G. intestinalis strains with different susceptibility/resistance to albendazole and nitazoxanide and evaluate its effect on the distribution of parasite cytoskeletal proteins and its in vivo giardicidal activity. METHODS CMC-20 activity was tested against two isolates from patients with chronic and acute giardiasis, an experimentally induced albendazole resistant strain and a nitazoxanide resistant clinical isolate. CMC-20 effect on the distribution of parasite cytoskeletal proteins was analysed by indirect immunofluorescence and its activity was evaluated in a murine model of giardiasis. FINDINGS CMC-20 showed broad activity against susceptible and resistant strains to albendazole and nitaxozanide. It affected the parasite microtubule reservoir and triggered the parasite encystation. In this process, alpha-7.2 giardin co-localised with CWP-1 protein. CMC-20 reduced the infection time and cyst load in feces of G. muris infected mice similar to albendazole. MAIN CONCLUSIONS The in vitro and in vivo giardicidal activity of CMC-20 suggests its potential use in the treatment of giardiasis.


Subject(s)
Humans , Animals , Mice , Thiazoles/pharmacology , Albendazole/pharmacology , Giardia lamblia/drug effects , Cytoskeletal Proteins/drug effects , Antiprotozoal Agents/pharmacology , Thiazoles/chemistry , Time Factors , Albendazole/chemistry , Fluorescent Antibody Technique, Indirect , Parasitic Sensitivity Tests , Antiprotozoal Agents/chemistry
6.
Arq. Inst. Biol ; 86: 0202018, 2019. tab
Article in English | LILACS, VETINDEX | ID: biblio-979668

ABSTRACT

In recent years, compounds with biological properties produced by plants have received attention as an alternative to control microorganisms. Essential oils extracted from green leaves of Eucalyptus sp. have been demonstrated to have antimicrobial activities, but so far there are no reports of antimicrobial activity of essential oils extracted from dried leaves of Eucalyptus staigeriana. So, the objectives of this study were to determine the chemical composition of the essential oils obtained from dried leaves of E. staigeriana (EOdlES) and to evaluate in vitro antimicrobial and antibiofilm activities of EOdlES against gram-positive and gram-negative, resistance and multiresistant Enterococcus faecalis isolated from food and clinical samples. The characterization of EOdlES was performed by gas chromatography-mass spectrometry (GC/MS). For this study, 26 bacterial strains were used, which included 11 reference strains and 15 antibiotic resistant and multiresistant E. faecalis strains. Antimicrobial activities of EOdlES against gram-positive and gram-negative were determined using the disc diffusion method. The minimum inhibitory concentration (MIC) value was evaluated by a microbroth dilution technique. The antibiofilm effects were assessed by microtiter plate method. As a result, 21 compounds were identified, being oxygenated monoterpenes (69.58%) the major chemical family. EOdlES showed only antimicrobial activity against gram-positive strains. E. faecalis resistant and multiresistant strains show the lowest MIC (3.12 to 6.25%), when compared with reference E. faecalis strain. EOdlES has the ability to inhibit the biofilm formation, but little or none ability to inhibit the preformed biofilm. This study demonstrates that EOdlES is a promising alternative to control important foodborne and clinic gram-positive resistant bacteria.(AU)


Nos últimos anos, compostos com propriedades biológicas produzidas por plantas têm recebido atenção como alternativa de controle de micro-organismos. Óleos essenciais extraídos de folhas verdes de Eucalyptus sp. têm demonstrado atividades antimicrobianas. No entanto, até o momento não há nenhum relato de atividade antimicrobiana de óleos essenciais extraídos de folhas secas de Eucalyptus staigeriana. O objetivo deste estudo foi determinar a composição química dos óleos essenciais obtidos de folhas secas de E. staigeriana e avaliar in vitro a sua atividade antimicrobiana e de antibiofilme contra gram-positivas e gram-negativas e também resistentes e multirresistentes de Enterococcus faecalis isolados de amostras de alimentos e clínicas. A caracterização de E. staigeriana foi realizada por CG-EM. Para este estudo foram utilizadas 26 cepas bacterianas, que incluíram 11 cepas referência e 15 cepas de E. faecalis resistentes a antibióticos. A atividade antimicrobiana de E. staigeriana contra gram-positivas e gram-negativas foi determinada utilizando o método de disco-difusão. Os valores da concentração inibitória mínima foram avaliados pela técnica de microdiluição. Os efeitos de antibiofilme foram avaliados pelo método de placa de microtitulação. Como resultado, 21 compostos foram identificados, sendo monoterpenos oxigenados (69,58%) a grande família química. E. staigeriana mostrou apenas atividade antimicrobiana contra cepas gram-positivas. Cepas de E. faecalis resistentes e multirresistentes mostraram a menor concentração inibitória mínima (3,12 para 6,25%) quando comparado com a cepa referência de E. faecalis. E. staigeriana apresentou a capacidade de inibir a formação de biofilme, mas pouca ou nenhuma capacidade de inibir o biofilme pré-formado. Este estudo demonstra que o óleo essencial obtido de folhas secas de E. staigeriana é uma alternativa promissora para controle importante de bactérias gram-positivas resistentes de origem alimentar e clínicas.(AU)


Subject(s)
Oils, Volatile , Drug Resistance, Bacterial , Eucalyptus/chemistry , Anti-Infective Agents
7.
Journal of Jilin University(Medicine Edition) ; (6): 551-557, 2019.
Article in Chinese | WPRIM | ID: wpr-841690

ABSTRACT

Objective: To explore the effects of eriCF1 and eriCF2 genes under the condition of different fluoride concentrations on the fluoride resistance of Streptococcus mutans (S. mutans) fluoride-resistant strain UA159-FR, and to elucidate the relationship between the differential expressions of eriCF genes and the fluoride resistance of S. mutans fluoride-resistant strain. Methods: The recombinant E. coli competent cells BL21 were divided into eriCF1 group (eriCF1+ Peasy-Blunt E2), eriCF2 group (eriCF2+ Peasy-Blunt E2) and KZ group (Peasy-Blunt E2). After gene cloning and IPTG induction, the expression levels of EriCF1 and EriCF2 proteins in three groups were detected, and the concentrations of bacterial solution and the growth rates of bacterium of strains in three groups were determined under different concentrations of fluoride conditions (1. 5, 2.0, 2.5, and 3. 0 g middot; L-1 sodium fluoride); the growth curves were drawn. Results: At logarithmic phase (8 h) and stable phase (16 h), the final concentrations of bacterial solution and the growth rates of the strains in three groups under different concentrations of fluorine environments (1. 5, 2. 0, 2. 5 and 3. 0 g middot; L-1 sodium fluoride) were compared in the same group, and the final concentrations and the growth rates of bacterial solution of the strains in three groups were decreased with the increasing of sodium fluoride concentration; the final concentrations and the growth rates of bacterial solution results were eriCF2 group > eriCF1 group > KZ group (P<0. 05 or P<0. 01).compared between three groups under the same concentration of sodium fluoride, the concentration of bacterial solution in eriCF2 group was increased significantly compared with eriCF1 group (P<0. 01). Conclusion: Both eriCF1 and eriCF2 genes can enhance the fluoride resistance of E. coli, and the fluoride resistance of E. coli expressing eriCF2 gene is stronger than that of E. coli expressing eriCF1 gene.

8.
Clinical Medicine of China ; (12): 41-43, 2016.
Article in Chinese | WPRIM | ID: wpr-489157

ABSTRACT

Objective To explore the efficacy of tigecycline combined with cefoperazone/sulbactam in the treatment of infections due to multiple drug resistant strains and pandrug-resistant acinetobacter baumannii, so as to guide the reasonable clinical medication.Methods A total of 16 cases of ventilator associated pneumonia caused by multiple drug resistant strains and pandrug-resistant acinetobacter baumannii treated in the First Hospital of Shijiazhuang from November 2012 to November 2014 were retrospectively analyzed, and the severity of the infection, clinical efficacy and mortality were observed.Results The multiple drug resistant strains and pandrugresistant acinetobacter baumannii were frequently detected in the 16 patients.Fifteen cases had been used other antibiotics before tigecycline, such as imipenem, cefoperazone/Shubatan, minocycline etc.The severity of underlying disease was assessed with the acute physiology and chronic health score(APACHE Ⅱ sore) within 24 h of admission, on the first day of tigecycline (TGC) therapy and after 7 days of TGC therapy.It showed that the average APACHE Ⅱ score were (25±6.0), (24.2±6.4) and (17.8±6.6) within 24 hours of admission(P<0.01), on the first day of TGC therapy and after 7 days of TGC therapy.Thirty days after application of the TGC, the bacterial eradication rate was 56.25% (9/16).The effective rate was 87.5% (14/16).The failure rate was 12.5% (2/16).Conclusion The effect of the tigecycline combined with cefoperazone/sulbactam on the clearance of the multiple drug resistant strains and pandrug-resistant acinetobacter baumanniiis is satisfied.

9.
Bol. latinoam. Caribe plantas med. aromát ; 13(6): 517-526, nov.2014. ilus, tab
Article in English | LILACS | ID: lil-795822

ABSTRACT

The study aimed to evaluate the bactericidal activity of oil essential and dillapiole from P. aduncum against standard and multidrug-resistant strains of Staphylococcus spp. The oil showed antimicrobial action against these strains, but better results were obtained for the standards strains of S. epidermidis and S. aureus, with MIC of 250 and 500 ug/mL, respectively. Dillapiolle was less effective than the oil against the same standard and multi-drug resistant strains (MIC =1000 ug/mL). However, when dillapiolle was tested in combination with myristicin, another component of the oil, it increased its bactericidal activity and showed a synergistic action...


El objetivo del estudio fue evaluar la actividad bactericida de los aceites esenciales y dillapiole de P. aduncum contra cepas estándar y multirresistentes de Staphylococcus spp. El aceite mostró acción antimicrobiana frente a estas cepas, pero se obtuvo mejores resultados para las cepas de S. epidermidis y S. aureus, con MIC de 250 y 500 ug/ml, respectivamente. Dillapiolle fue menos eficaz que el aceite contra cepas estándar y multirresistentes (MIC = 1000 ug/ml). Sin embargo, cuando dillapiolle fue probado en combinación con la miristicina, otro componente del aceite, que aumentó su actividad bactericida y mostró una acción sinérgica...


Subject(s)
Humans , Oils, Volatile/pharmacology , Anti-Bacterial Agents/pharmacology , Plant Extracts/pharmacology , Piper/chemistry , Allyl Compounds/pharmacology , Benzyl Compounds/pharmacology , Drug Resistance, Multiple, Fungal , Monoterpenes/pharmacology , Staphylococcus
10.
Article in English | IMSEAR | ID: sea-162897

ABSTRACT

This review details the success of different probiotic agents to provide protection in the host from infection by pathogenic microbial agents. Probiotics are bacteria that interfere and kill pathogens but the mechanisms employed by these agents in preventing infection and disease vary from host to host. In this review the use of probiotics in evolutionary distinct hosts are discussed. The early discovery of antibiotics (such as penicillin and streptomycin) and newer generation drugs have played and continue to play vital roles in controlling infections by pathogenic agents. The extensive and indiscriminate uses of antibiotics have contributed to the survival of resistant microbial agents that cannot be controlled by conventional antibiotics. The resistant strains damage cells, tissues and organs resulting in injury and or death to the host. Probiotic agents block sites pathogenic agents need for adherence to surfaces and simultaneously activates innate and adaptive components of the immune system. The multipronged attack by probiotics are more efficient than just relying on antibiotics to disrupt cell wall structures and or poison metabolic pathways in pathogenic agents.

11.
Rev. bras. plantas med ; 15(2): 199-207, 2013. ilus, graf, tab
Article in Portuguese | LILACS | ID: lil-677027

ABSTRACT

No presente estudo objetivou-se avaliar a atividade antimicrobiana e sinérgica de 4 frações das folhas de Schinopsis brasiliensis Engl (F1', F2', F1" e F2") frente às cepas Staphylococcus aureus MRSA multirresistentes. Os métodos utilizados foram poços de difusão em ágar, concentração mínima inibitória (CMI) - diluição em ágar, e bioautografia. Nos resultados bioautográficos observou-se três halos de inibição relacionados, no mínimo, à quatro constituintes ativos; sendo dois deles isolados das folhas (galato de metila e ácido gálico). A F2" (200∝g/mL) apresentou halos de inibição de 16 e 19mm frente as cepas de S. aureus multirresistente e Klebsiella pneumoniae, e CMI 100∝g/mL, respectivamente. Quanto as análises das associações das frações F1" ou F2" (25 e 50∝g/mL) com a tetraciclina e oxacilina, mostraram ações aditiva e sinérgica para a F2" (50∝g/mL), embora não suficiente para que a CMI atingisse valores inferiores a 2 e 4∝g/mL, necessário para serem classificadas como cepas sensíveis a oxacilina e tetraciclina, respectivamente. "Assim, conclui-se que a F2" das folhas de S. brasiliensis apresentou potencial antimicrobiano frente às cepas de S. aureus MRSA multirresistentes e que as associações das frações com os antibióticos testados não apresentaram benefícios não justificando o uso concomitante.


The aim of this study was to evaluate the antimicrobial and synergic activity of 4 leaf fractions of Schinopsis brasiliensis Engl (F1', F2', F1" and F2") against multidrug-resistant Staphylococcus aureus strains. The used methods were agar well diffusion, minimum inhibitory concentration (MIC) - agar dilution, and bioautography. The bioautographic results showed three inhibition zones that corresponded to at least four active compounds, two of which (methyl gallate and gallic acid) have already been isolated from leaves. The F2" (200∝g/mL) fraction showed inhibition zones of 16 mm and 19 mm against S. aureus multidrug-resistant and Klebsiella pneumoniae strains and a MIC value of 100∝g/mL, respectively. The analyses of associations of fraction F1" or F2" (25 and 50∝g/mL) with tetracycline and oxacillin showed additive and synergistic action for F2" (50∝g/mL), although it was not enough to decrease the MIC values to less than 2 and 4∝g/mL, necessary to classify the strains as susceptible to oxacillin and tetracycline, respectively. Thus, it was concluded that F2" from the leaves of S. brasiliensis showed antimicrobial potential against multidrug-resistant MRSA strains, and the associations of the fractions with the tested antibiotics showed no benefits, not justifying their concomitant use.


Subject(s)
Plant Leaves/anatomy & histology , Anacardiaceae/classification , Anti-Infective Agents/analysis , Staphylococcus aureus/isolation & purification , Colony Count, Microbial/methods , Microbial Sensitivity Tests/methods , Drug Resistance, Multiple
12.
Chinese Journal of Nosocomiology ; (24)2009.
Article in Chinese | WPRIM | ID: wpr-584938

ABSTRACT

OBJECTIVE To approach the constituent ratio and drug-resistance of Gram-negative bacilli(GNB) in nosocomial infections and provide the scientific evidence for the clinical treatment of infectious diseases.METHODS Totally 376 GNB strains isolated from our hospital were cultured and identified according to the National Clinical Laboratory Operation Rules.The antibiotic susceptibility test was performed by K-B method and the constituent ratio of GNB was analyzed statistically.RESULTS The pathogens with strains having higher isolating rate were Pseudomonas aeruginosa(21.5%),Klebsiella pneumoniae(17.6%),Acinetobacter baumannii(14.4%),Escherichia coli(10.9%),and Stenotrophomonas maltophilia(5.9%).The drug sensitivity tests in vitro showed that these strains were multiresistant.Except for natural drug-resistant S.maltophilia,16.0% of P.aeruginosa and 24.1% of A.baumannii were resistant to imipenem.The average detection rate of the extended spectrum ?-lactamase(ELBLs) producers was 40.2%.CONCLUSIONS The resistance status of GNB is very serious.We must strengthen monitoring and controlling of drug resistance.

13.
Mycobiology ; : 270-273, 2008.
Article in English | WPRIM | ID: wpr-729611

ABSTRACT

Trichoderma spp. cause large crop losses of the cultivated shiitake mushroom, Lentinula edodes. We bred several shiitake strains that are resistant to Trichoderma spp. using di-mon mating to establish a useful method for controlling the greenmold disease. We examined the competitive ability of L. edodes against Trichoderma spp. using a dual culture system to select resistant strains. By screening Trichoderma-resistant strains, we found that among 11 parental strains, 4 strains, including KFRI 36, were confirmed resistant strains. They showed especially strong resistance to T. harzianum, which formed deadlock after mycelial contact and then invaded into the territory of T. harzianum. KFRI 171 also showed resistance to T. atroviride strains. Among 13 strains, which were made by hybridization of shiitake strains, 5 were confirmed to be resistant to Trichoderma, including KFRI 58-1. Their resistance was not correlated to the resistant activity of their parents' strains. Two strains lose resistance and two strains acquire resistance compared to their parents' strains. In SEM observation, the mycelium of L. edodes at the interaction zone of Lentinula-Trichoderma was rugged and swollen by T. harzianum.


Subject(s)
Humans , Breeding , Chimera , Lentinula , Mass Screening , Mycelium , Parents , Shiitake Mushrooms , Trichoderma
14.
Chinese Journal of Nosocomiology ; (24)2004.
Article in Chinese | WPRIM | ID: wpr-594782

ABSTRACT

OBJECTIVE To study the disinfectant resistance of multi-drug resistant Escherichia coli strains isolated clinically,and to find out the efficacy of disinfectants commonly used in killing multi-drug resistant E.coli strains.METHODS Minimal inhibitory concentration(MIC) and suspension quantitative germicidal test were used.Compared with standard strains,strains of multi-drug resistant E.coli isolated clinically were determined the resistance to four kinds of disinfectants including benzalkonium bromide etc.RESULTS A higher MIC of benzalkonium bromide compared with standard strains was observed in 61.9% of all 21 multi-drug resistant E.coli strains,and as for povidone iodine and NaClO,the ratio was 71.4% and 14.3%,respectively.All multi-drug resistant E.coli strains had the same MICs of peroxyacetic acid with standard strains.The above-mentioned 4 disinfectants commonly used at the routine concentrations killed 100% of the resistant strains of E.coli within 5 minutes.CONCLUSIONS The resistance to benzalkonium bromide and povidone iodine of multi-drug resistant E.coli isolated clinically is higher than standard strains;and 4 kinds of disinfectants commonly used are effective for multi-drug resistant E.coli strains isolated clinically.

15.
Chinese Journal of Practical Internal Medicine ; (12)2001.
Article in Chinese | WPRIM | ID: wpr-565897

ABSTRACT

Community-acquired pneumonia(CAP)is one of the common infections threating human health.To optimize CAP treatment strategy,the global professional organizations updated the guidelines,mainly in the following four aspects:(1)CAP severity of the classification.(2)The place accepts Initial treatment.(3)The importance of monitoring drug-resistant strains.(4)Atypical pathogens become more and more important.The position of antibacterial drugs in the treatment guidelines for CAP changed.The effect of fluoroquinolone in most guidelines has been affirmed treatment of.Since CAP should cover atypical pathogens,atypical pathogens resistant in China is analyzed to update guideline in the future as a reference guide.

SELECTION OF CITATIONS
SEARCH DETAIL